OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death
Jonathan Mannion, Valentina Gifford, Benjamin R. Bellenie, et al.
Immunity (2024) Vol. 57, Iss. 7, pp. 1514-1532.e15
Open Access | Times Cited: 8
Jonathan Mannion, Valentina Gifford, Benjamin R. Bellenie, et al.
Immunity (2024) Vol. 57, Iss. 7, pp. 1514-1532.e15
Open Access | Times Cited: 8
Showing 8 citing articles:
DNA Tetrahedron-Driven Multivalent Proteolysis-Targeting Chimeras: Enhancing Protein Degradation Efficiency and Tumor Targeting
Shiqing Li, Tao Zeng, Zhixing Wu, et al.
Journal of the American Chemical Society (2025)
Closed Access
Shiqing Li, Tao Zeng, Zhixing Wu, et al.
Journal of the American Chemical Society (2025)
Closed Access
Prognostic models of immune-related cell death and stress unveil mechanisms driving macrophage phenotypic evolution in colorectal cancer
Hao Liu, Chuhan Zhang, Sanfei Peng, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Hao Liu, Chuhan Zhang, Sanfei Peng, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
JTC801 regresses uveal melanoma progression through novel methuosis-like cell death via lysosomal dysfunction
Qiuyan Liu, Mingyan Huang, Xinpei Ji, et al.
Research Square (Research Square) (2025)
Closed Access
Qiuyan Liu, Mingyan Huang, Xinpei Ji, et al.
Research Square (Research Square) (2025)
Closed Access
RIPK1 is essential for Herpes Simplex Virus-triggered ZBP1-dependent necroptosis in human cells
Oluwamuyiwa T. Amusan, Shuqi Wang, Chaoran Yin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Oluwamuyiwa T. Amusan, Shuqi Wang, Chaoran Yin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Development of a RIPK1 degrader to enhance antitumor immunity
Xin Yu, Dong Lu, Xiaoli Qi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Xin Yu, Dong Lu, Xiaoli Qi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
RIPK1: Inflamed if you do, inflamed if you don’t
Nicholas Hubbard, Andrew Oberst
Immunity (2024) Vol. 57, Iss. 7, pp. 1443-1445
Closed Access
Nicholas Hubbard, Andrew Oberst
Immunity (2024) Vol. 57, Iss. 7, pp. 1443-1445
Closed Access
Targeted Degradation of Receptor-Interacting Protein Kinase 1 to Modulate the Necroptosis Pathway
Hiroyuki Inuzuka, Chao Qian, Yihang Qi, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 11, pp. 3518-3526
Open Access
Hiroyuki Inuzuka, Chao Qian, Yihang Qi, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 11, pp. 3518-3526
Open Access
RIPK1 inhibition in malignant cells potentiates immunotherapy and radiotherapy outcome
Jonathan Pol, Andrea Checcoli, Manuela Lizarralde-Guerrero, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Jonathan Pol, Andrea Checcoli, Manuela Lizarralde-Guerrero, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
PTGES3 proteolysis using the liposomal peptide-PROTAC approach
Shiwei Liu, Fukang Yuan, Hui Dong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
Shiwei Liu, Fukang Yuan, Hui Dong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
